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Results: Platelets in non-diabetic patients demonstrated miRNA expression pro-
files comparable to previously published data. The miRNA expression profiles of
platelets in diabetics were similar. Statistical analysis unveiled only three miR-
NAs (miR-377-5p, miR-628-3p, miR-3137) with high reselection probabilities in
resampling techniques, corresponding to signatures with only modest discrimina-
tory performance. Functional annotation of predicted targets for these miRNAs
pointed towards an influence of diabetes mellitus on mRNA processing.
Conclusions: We did not find any major differences in platelet miRNA profiles be-
tween diabetics and non-diabetics. Minor differences pertained to miRNAs asso-
ciated with mRNA processing. Thus, previously described differences in plasma
miRNAs between diabetic and nondiabetic patients cannot be explained by plain
changes in the platelet miRNA profile.
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The olive constituent oleuropein prevents cardiac
doxorubicin-induced changes in eNOS expression, apoptotic
mediators and energy metabonomics in rats
I. Andreadou1, K. Ioannidis1, S. Kostidis1, F. Sigala2, D. Farmakis3 ,
A.L. Skaltsounis1, D.T.H. Kremastinos3, M. Anastasiou-Nana3, E. Mikros1,
E.K. Iliodromitis3. 1University of Athens, Faculty of Pharmacy, Athens, Greece;
2Hippokratio Hospital Dept of Surgery, Athens, Greece; 3Attikon Hospital, 2nd
University Department of Cardiology, Athens, Greece
Purpose: Doxorubicin (DXR) causes cardiotoxicity through nitro-oxidative stress,
but the exact pathogenesis is not fully elucidated. Oleuropein (OLEU), a polyphe-
nolic constituent of olive and its products, prevents acute and chronic DXR-
induced cardiotoxicity. We evaluated mechanisms potentially involved in chronic
DXR cardiotoxicity, including eNOS, pro-apoptotic mediators and energy metabo-
nomics as well as OLEU impact on these mechanisms.
Methods: Ninety rats were divided into 6 groups: Control group, no treatment;
OLEU-70 and OLEU-140 groups, 70 and 140 mg/kg of OLEU, respectively, given
intraperitoneally (ip) for 2 weeks; DXR group, 18mg/kg of DXR ip, divided into 6
equal doses and given over a period of 2 weeks; OLEU-70-DXR and OLEU-140-
DXR groups, combined OLEU and DXR as previously described. The rats were
finally sacrificed and the hearts were excised for tissue assessment of eNOS, Akt
and AMPK by immunohistochemistry and Western-Blot. NMR spectra of tissue
extracts was also recorded and analyzed further by multivariate statistics.
Results: DXR group had lower eNOS, Akt and AMPK activation compared to
controls and all OLEU groups. The NMR-based metabonomic study depicted dif-
ferences in the metabolic profile of DXR compared to all other groups (Figure)
suggesting an impaired energy metabolism in this group and rehabilitation with
OLEU administration. The inhibition of AMPK activation by DXR, correlated with
the change in the profile of cardiac energy substrate utilization with a decrease in
glucolysis and fatty acids oxidation.
Conclusion: Impaired eNOS, Akt and AMPK expression and cardiac energy
metabolism disruption is involved in chronic DXR cardiotoxicity; OLEU prevented
those changes, thus providing a potential protective agent against DXR-induced
cardiomyopathy.
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Effect of abrupt preload reduction on left atrial and ventricular
pressures in a multi-scale mathematical model of the
cardiovascular system
A. Pironet1, P.C. Dauby1, S. Kosta1, S. Paeme1, J.G. Chase2, P. Kolh3,
T. Desaive1 on behalf of GIGA-Cardiovascular Sciences. 1University of
Liege (ULg), GIGA-Cardiovascular Sciences, Liège, Belgium; 2University of
Canterbury, Christchurch, New Zealand; 3University of Liege Hospital (ULg
CHU), GIGA-Cardiovascular Sciences, Liège, Belgium
Purpose: The time-varying elastance theory has been widely used to describe
left atrial and ventricular behaviors. However, the applicability of this theory to the
left atrium is not fully established. Therefore, we used a different type of model,
based on a description of sarcomere contraction. We aim to observe if the model
behaves similarly to experimental observations during inferior vena cava occlu-
sion (IVCO) experiments.
Methods: We used a multi-scale model of the cardiovascular system in which
left ventricular and atrial pressures are inferred from a sarcomere model. In this
model, we reproduced IVCO experiments by a fourfold increase of the vena cava
resistance. As in experimental settings, we observed the variation of measure-
ments before and 5 heartbeats after modification of the resistance. These mea-
surements were: maximum a and v wave pressures, minimum and end-diastolic
ventricular pressures, slopes of a and v waves and maximum transmitral pressure
gradients during early and late ventricular filling.
Results: Among the 8 measurements, in the model, 7 followed a similar decrease
as experimentally observed. The only measurement that increased is the slope of
the v wave. A possible reason for this discrepancy could be that in experimental
protocols, vena cava is obstructed far from the heart. In our model, since the
vena cava is only represented by a windkessel model, this geographical difference
cannot be accounted for.
Measurements before and after IVCO
Measurement Units Experiments Model simulations
Baseline IVCO Baseline IVCO
Maximum a wave pressure mmHg 6.6 4.3 9.64 4.95
Maximum v wave pressure mmHg 5.6 2.9 14.31 14.08
Minimum ventricular pressure mmHg 1 −0.4 7.04 14.08
End-diastolic ventricular pressure mmHg 6.5 3.8 10.24 4.95
Slope of the a wave mmHg/s 60 37 54.88 29.16
Slope of the v wave mmHg/s 21 13 18.74 41.05
Maximum early pressure gradient mmHg 2.8 2.4 1.50 1.08
Maximum late pressure gradient mmHg 1.2 0.9 2.43 1.70
Conclusion: The developed multi-scale model inferring ventricular and atrial con-
traction from a sarcomere model correctly represents the left atrial behavior and
responds to IVCO experiments as physiologically expected.
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Structural modifications of apelin-12 molecule differently affect
cardiac function
S.V. Lakomkin, E.V. Lukoshkova, V.V. Ermishkin, V.L. Lakomkin, A.A. Abramov,
Z.D. Bespalova, S.N. Tereschenko, V.I. Kapelko. Cardiology Research and
Production Center, Institute of Clinical Cardiology, Moscow, Russian Federation
Purpose: Apelin-12, the short active fragment of natural apelin-77, and its syn-
thetic analog apelin-12-2 have been shown to exert beneficial effects in experi-
mental heart failure. The aim of this study was to explore effects of other analogs
of apelin-12 molecule.
Methods: The cardiac function of ketamine-anesthetized Wistar rats has been
studied using catheterization of the left ventricle (LV) with Millar micromanome-
ter and thoracic electrical impedance. Electric and pressure signals were sent
to a computer via an analog-to-digital converter. Bolus injections of apelins were
applied with subsequently increasing rate (0.05-5.0 mg/kg) at 10-min intervals.
Results: Substitution of methionine in apelin-12 molecule on norleucine (apelin-
12-1 analog) shortened duration of hypotensive effect due to more rapid recovery
of LV systolic pressure and LV dP/dtmax associated with an increase dP/dtmax/P
index and the shortening of duration of preejection time. Further modifications
were made on the basis of apelin-12-1 molecule. Replacement of arginine at
N-end on methylarginine (apelin-12-2 analog) was associated with removal of
hypotensive effect, increased enddiastolic and systolic LV pressures as well as
the rate of increment of impedance signal suggesting increased ejection speed.
Replacement of hydroxyl group at C-end of this molecule by amide group (apelin-
12-3 analog) reduced the extent of positive inotropic effect, but increased the
relaxation constant. Finally, replacement in the latter molecule of methylarginine
at the N-end by nitroarginine (apelin-12-4 analog) while retaining relaxation ac-
celeration, exerted hypotensive effect with a reduction of LV systolic pressure, but
slightly increased ejection speed and dP/dtmax/P index.
Conclusions: Hypotensive effect of apelin analogs is associated with the pres-
ence of arginine and not methylarginine at N-end of molecule. The combination of
methylarginine at N-end and OH-group at C-end facilitate positive inotropic effect
of an analog. The presence of NH2-group instead of OH-group at C-end results in
fastened relaxation. Thus, these modifications are capable to influence different
targets in myocardial and vascular cells.
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Potential etiology of diabetic cardiomyopathy
Y. Bai, J. Zhou, A. Sun, J. Qian, Y. Zou, J. Ge. Shanghai Institute of
Cardiovascular Diseases, Zhongshan Hospital-Fudan Univerisity, Shanghai,
China, People’s Republic of
The objective of the current study was to determine whether the negative effects
of diabetes on the adult heart are dictated by defects in resident cardiac stem
cells (CSCs) growth and lineage commitment.Type I insulin-dependent diabetes
mellitus (IDDM) was induced in mice by streptozotocin administration. The kinet-
ics of CSCs and cardiomyocytes was measured 1, 3, 5, 10, 20, 30, 60, and 90
days after the onset of diabetes, by analyzing 14C birth dating of cardiac cells
by Accelerator Mass Spectrometry, which gives the information of the turnover of
cardiomyocytes and CSCs in the presence and absence of diabetes. Additionally,
the number of cardiomyocytes dying by apoptosis and necrosis were measured
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